Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrendipine, Hydrochlorothiazide, Captopril, and Beijing Hypotensive No.0 in Tibetan Hypertension
NCT02217852Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitrendipine, hydrochlorothiazide, captopril, Compound Hypotensive Tablets in hypertension (HTN), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
nitrendipinehydrochlorothiazidecaptoprilCompound Hypotensive Tablets
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02217852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217852.